Edwards Lifesciences Corp/ US28176E1082 /
03/05/2024 21:59:54 | Chg. +0.23 | Volume | Bid- | Demandez à- | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
85.29USD | +0.27% | 74,359 Chiffrre d'affaires: 6.37 Mio. |
-Bid taille: - | -Ask la taille: - | 51.37 Mrd.USD | - | 36.90 |
GlobeNewswire
21:17
ROSEN, A LONGSTANDING LAW FIRM, Encourages Malibu Boats, Inc. Investors to Secure Counsel Before Imp...
GlobeNewswire
20:36
ODU Confers More Than 2,600 Degrees During its 2024 Spring Commencement Exercises
GlobeNewswire
19:48
Studies Presented at AUA 2024 Highlight Latest Research on Voiding Dysfunction and BPH
GlobeNewswire
19:04
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Th...
GlobeNewswire
18:44
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electri...
GlobeNewswire
18:12
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investor...
GlobeNewswire
17:06
MS INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Morgan Stanley Investors to Inquire ...
GlobeNewswire
16:47
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:30
NASDAQ: ADSK: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Law...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page